A detailed history of New Edge Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, New Edge Advisors, LLC holds 154,079 shares of ABT stock, worth $17.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
154,079
Previous 170,850 9.82%
Holding current value
$17.7 Million
Previous $17.8 Million 1.05%
% of portfolio
0.12%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $1.68 Million - $1.98 Million
-16,771 Reduced 9.82%
154,079 $17.6 Million
Q2 2024

Aug 15, 2024

BUY
$100.73 - $112.44 $868,292 - $969,232
8,620 Added 5.31%
170,850 $17.8 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $997,508 - $1.1 Million
9,108 Added 5.95%
162,230 $18.4 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $122,207 - $149,592
1,355 Added 0.89%
153,122 $16.9 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $1.43 Million - $1.71 Million
-14,930 Reduced 8.96%
151,767 $14.7 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $26.8 Million - $29.9 Million
-265,857 Reduced 61.46%
166,697 $18.2 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $1.11 Million - $1.31 Million
11,461 Added 2.72%
432,554 $43.8 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $2.35 Million - $2.76 Million
24,709 Added 6.23%
421,093 $46.2 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $1.34 Million - $1.55 Million
13,868 Added 3.63%
396,384 $38.4 Million
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $1.77 Million - $2.14 Million
17,368 Added 4.76%
382,516 $41.6 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $3.88 Million - $4.73 Million
34,031 Added 10.28%
365,148 $43.2 Million
Q4 2021

Feb 17, 2022

BUY
$115.53 - $141.46 $7.18 Million - $8.79 Million
62,142 Added 23.1%
331,117 $46.6 Million
Q3 2021

Oct 29, 2021

BUY
$116.66 - $129.06 $1.52 Million - $1.68 Million
13,033 Added 5.09%
268,975 $31.8 Million
Q2 2021

Jul 22, 2021

BUY
$105.79 - $124.53 $1.88 Million - $2.22 Million
17,794 Added 7.47%
255,942 $29.7 Million
Q1 2021

Apr 26, 2021

BUY
$108.84 - $128.23 $2.77 Million - $3.26 Million
25,405 Added 11.94%
238,148 $28.5 Million
Q4 2020

Jan 27, 2021

BUY
$105.0 - $114.42 $16.9 Million - $18.4 Million
160,897 Added 310.34%
212,743 $23.3 Million
Q3 2020

Nov 03, 2020

BUY
$91.64 - $111.29 $193,452 - $234,933
2,111 Added 4.24%
51,846 $5.64 Million
Q2 2020

Jul 29, 2020

SELL
$76.57 - $98.0 $544,106 - $696,388
-7,106 Reduced 12.5%
49,735 $4.55 Million
Q1 2020

May 04, 2020

BUY
$62.82 - $91.86 $389,484 - $569,532
6,200 Added 12.24%
56,841 $4.49 Million
Q4 2019

Jan 31, 2020

BUY
$78.51 - $87.4 $480,245 - $534,625
6,117 Added 13.74%
50,641 $4.4 Million
Q3 2019

Nov 06, 2019

BUY
$81.84 - $88.74 $692,775 - $751,184
8,465 Added 23.48%
44,524 $3.72 Million
Q2 2019

Aug 05, 2019

BUY
$72.88 - $85.0 $36,585 - $42,670
502 Added 1.41%
36,059 $3.03 Million
Q1 2019

May 09, 2019

BUY
$66.22 - $80.06 $325,868 - $393,975
4,921 Added 16.06%
35,557 $204,000
Q4 2018

Jan 29, 2019

BUY
$65.56 - $74.27 $145,805 - $165,176
2,224 Added 7.83%
30,636 $2.2 Million
Q3 2018

Oct 29, 2018

BUY
$60.81 - $73.36 $229,132 - $276,420
3,768 Added 15.29%
28,412 $2.08 Million
Q2 2018

Jul 19, 2018

SELL
$57.57 - $63.54 $55,382 - $61,125
-962 Reduced 3.76%
24,644 $1.5 Million
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $103,874 - $117,442
1,846 Added 7.77%
25,606 $1.49 Million
Q4 2017

Feb 08, 2018

SELL
$53.68 - $57.47 $51,157 - $54,768
-953 Reduced 3.86%
23,760 $1.4 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $42,196 - $47,095
878 Added 3.68%
24,713 $1.35 Million
Q2 2017

Aug 16, 2017

BUY
N/A
23,835
23,835 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.